[AVDL] YoY Quarter Result on 31-Mar-2017 [#Q1]

Stock
[AVDL] Avadel Pharmaceuticals plc
Announcement Date
10-May-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- 447.32%
YoY- 506.37%
Quarter Report
AVDL's Result
AVDL's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Revenue 12,243 16,437 33,293 52,507 36,216 32,726 9,175 4.92%
PBT -10,375 -13,392 -14,563 34,449 765 22,120 -29,435 -15.93%
Tax -9,510 -374 -2,327 8,539 7,141 10,473 -2,797 22.60%
NP -865 -13,018 -12,236 25,910 -6,376 11,647 -26,638 -43.48%
Tax Rate - - - -24.79% -933.46% -47.35% - -
Total Cost 13,108 29,455 45,529 26,597 42,592 21,079 35,813 -15.41%
Ratio Analysis
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
NP Margin -7.07 -79.20 -36.75 49.35 -17.61 35.59 -290.33 -46.13%
Per Share
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
EPS -0.02 -0.35 -0.32 0.63 -0.16 0.29 -0.94 -47.32%
EPS Diluted -0.02 -0.35 -0.32 0.61 -0.15 0.27 -0.94 -47.32%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.